MeredithChukMDMSc

Pediatric Hematology & Oncology • Baltimore, MD

Medical Advisor

Join to view full profile

Dr. Chuk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chuk's full profile

Already have an account?

Office
Johns Hopkins Hospital 600 North Wolfe St
CMSC 800
Baltimore, MD 21287
Phone+1 410-955-8751

Fax+1 410-955-0028

Education & Training

Duke UniversityMS, clinical research, 2009
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2005 - 2008
National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2005 - 2008
UPMC Medical EducationResidency, Pediatrics, 2001 - 2004
Pennsylvania State University College of MedicineClass of 2001

Certifications & Licensure

MD State Medical License 2006 - 2026
PA State Medical License 2004 - 2016
WV State Medical License 2011 - 2014

Publications & Presentations

PubMed

3 citations
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials.
Mark D Stewart, Bruce McCall, Marcelo Pasquini, Allen S Yang, Carolyn D Britten
Cytotherapy. 2022-07-01
39 citations
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.
Oladimeji Akinboro, Erin Larkins, Lee H Pai-Scherf, Luckson N Mathieu, Yi Ren
Clinical Cancer Research. 2022-06-01
2 citations
Recommendations for Dose Selection for Adolescent Patients in Relevant Adult Oncology Clinical Trials
Ruby Leong, Qi Liu, Lingjue Li, Jiang Liu, Yunzhao R. Ren
Clinical Pharmacology and Therapeutics. 2021-10-29

Abstracts/Posters

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis
Meredith Chuk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Houston Methodist and U.S. Department of Health and Human Services Partner to Expand Access to COVID-19 Monoclonal Antibody TreatmentMay 27th, 2021
UPMC on Expanded Eligibility Guidelines for COVID-19 Treatment – Pittsburgh, PennsylvaniaMay 26th, 2021
UPMC Touts Antibody Treatment for Covid-19May 26th, 2021
Join now to see all